The LGL (US:LGL)2025-11-13 13:58Financial Performance - For Q3 2025, LGL Group reported revenues of $1,108,000, a decrease of 6.0% from $1,179,000 in Q3 2024[2] - Net income for Q3 2025 was $772,000, or $0.14 per diluted share, compared to $72,000, or $0.01 per diluted share in Q3 2024, reflecting a 972.2% increase[3] - Total revenues for Q3 2025 decreased by 6.0% to $1,108,000 compared to $1,179,000 in Q3 2024[29] - Net income attributable to LGL Group common stockholders increased significantly by 972.2% to $772,000 from $72,000 year-over-year[29] - For the nine months ended September 30, 2025, total revenues were $2,950,000, down 5.9% from $3,135,000 in the same period of 2024[31] - Net income for the nine months increased by 159.2% to $762,000 compared to $294,000 in the prior year[31] Segment Performance - Electronic Instruments segment revenues grew by 1.7% to $661,000, while Merchant Investment revenues fell by 13.8% to $274,000[29] - The Electronic Instruments segment reported a 4.9% revenue increase to $1,650,000, while Merchant Investment revenues decreased by 15.1% to $783,000[31] Expenses and Margins - Gross margin improved to 52.8% in Q3 2025, up from 43.4% in Q3 2024, primarily due to sales of higher margin products[4] - Total expenses decreased by 5.1% to $988,000, with a notable reduction in Electronic Instruments expenses by 8.1%[29] - Engineering, selling, and administrative expenses increased to $676,000 in Q3 2025 from $673,000 in Q3 2024[25] - Corporate expenses decreased by 17.1% to $286,000, contributing to overall expense reduction[29] Cash and Investments - Cash and cash equivalents, along with marketable securities, totaled $41.6 million as of September 30, 2025[5] - The company experienced lower net investment income due to reduced yields on investments in U.S. Treasury money market funds[3] Shareholder Returns and Acquisitions - LGL Group returned $366,000 to shareholders through share repurchases in Q3 2025, representing approximately 51,463 shares[12] - The strategic acquisition of Morgan Group Holding Co. is progressing, with plans to purchase 1,000,000 shares at $2.00 per share[14] Order Backlog - The order backlog as of September 30, 2025, was $776,000, an increase of $440,000 from $336,000 at the end of 2024[8] Tax Benefits - The company experienced a significant tax benefit, with income tax expense decreasing by 1,504.2% to $(674,000)[29]